Considering the overall median fluorescence intensity (MFI) for specific EV markers (i.e., tetraspanins CD63, CD9 and CD81; Figure 1A) we observed that only EV-specific tetraspanin CD81 was significantly higher in COVID-19 patients than controls (P<0.05). This evidence concerns the gene CD81 and COVID-19.